Showing 11,401 - 11,420 results of 45,491 for search '(( 5 ((ng decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.71s Refine Results
  1. 11401

    DataSheet_1_The influence of 17β-estradiol plus norethisterone acetate treatment on markers of glucose and insulin metabolism in women: a systematic review and meta-analysis of ran... by Weijuan Cui (15536306)

    Published 2023
    “…The combined administration of 17β-estradiol and norethisterone acetate decreased HbA1c (WMD: -0.65%, 95% CI: -1.15 to -0.15; P=0.011), fasting glucose (WMD: -11.05 mg/dL, 95% CI: -16.6 to -5.5; P<0.001) and insulin (WMD: -1.35 mIU/L, 95% CI: -2.20 to -0.50; P=0.001) levels. …”
  2. 11402

    Exposure to estrogen or overexpression of Grx1 abolishes L-BOAA induced MMP loss in SH-SY5Y cells. by Uzma Saeed (49670)

    Published 2008
    “…MMP is maintained in SH-SY5Y pretreated with 17-β estradiol (C) and in cell lines overexpressing Grx1 (D). …”
  3. 11403

    Nakasone. AJP supple Table1, 2, 3 by Toru Aizawa (9001298)

    Published 2023
    “…<em>Hazard ratio and 95%CI of HGI and HbA1c to incident CKD</em></p> <p>  </p> <p>The data was obtained in Aizawa cohort, in which QR of HGI and HbA1c was almost the same as 0.48 and 0.50 (Table 1) so that scaling was omitted. …”
  4. 11404

    Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  5. 11405

    Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  6. 11406

    The effect on DCMD responses of adding wings to looming discs with varying <i>l/|v|</i>. by Roger D. Santer (117354)

    Published 2012
    “…Calculated angular subtenses for the looming disc and wing tip are plotted above mean DCMD responses in each case. For disc <i>l/|v|</i> 20.0 ms (B), 10.0 ms (C) and 6.0 ms (D), the addition of wings had subtle effects on the DCMD response time course, slightly augmenting spike rates in the early stages of approach but decreasing them during the final, highest frequency part of the DCMD response (see text); these effects were most apparent at higher <i>l/|v|</i> ratios. …”
  7. 11407
  8. 11408
  9. 11409
  10. 11410

    S1 File - by Kimesh Loganathan Naidoo (19697486)

    Published 2024
    “…Of the 45 015 admissions analysed, 1237(2·75%) demised with significant decreases in admissions during all the lockdown levels, with the most significant mean monthly decrease of 450(95%, CI = 657·3, -244·3) p<0·001 in level 5 (the most severe) lockdown. …”
  11. 11411
  12. 11412

    Transient dynamics and IFA for piecewise linear external drive. by Natalie Schieferstein (17996519)

    Published 2024
    “…Dotted horizontal lines mark reference drive , spike threshold <i>V</i><sub><i>T</i></sub> = 1, and reset potential <i>V</i><sub><i>R</i></sub> = 0. …”
  13. 11413
  14. 11414
  15. 11415
  16. 11416
  17. 11417

    WNT7A Regulation by miR-15b in Ovarian Cancer - Fig 5 by James A. MacLean II (2794756)

    Published 2016
    “…<p>(A) 5-aza-2’-dC treatment induces <i>miR-15b</i> expression (left) and decreases <i>WNT7A</i> expression (right) in OvCa cells. …”
  18. 11418
  19. 11419
  20. 11420

    Image_1_Exploring the potential of pheophorbide A, a chlorophyll-derived compound in modulating GLUT for maintaining glucose homeostasis.pdf by Saptadipa Paul (18132904)

    Published 2024
    “…To assess how pheophorbide A mechanistically acts on GLUT1 in pancreatic β cell, we transfected INS-1 cells with GLUT1–enhanced green fluorescent protein and checked how the treatment of pheophorbide A (0.50 µM) modulates GLUT1 trafficking using live-cell imaging. …”